Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation

Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation

Show other versions (1)

<p>Hematopoietic stem cells transplantation (HSCT) technology currently allows curing a lot of malignant and non-malignant diseases in adults and children. However, HSCT is highly toxic treatment. HSCT complications include the possibility of prolonged immunodeficiency, alloand autoimmune reac...

Full description

Bibliographic Details
Main Authors:	Yu. V. Skvortsova, A. E. Rudneva, V. M. Delyagin, Yu. A. Lerkhendorf, G. V. Tereshchenko, D. N. Balashov, M. A. Maschan, A. A. Maschan
Format:	Article
Language:	Russian
Published:	ABV-press 2015-06-01
Series:	Онкогематология
Subjects:	hematopoietic stem cell transplantation late complications after hematopoietic stem cells transplantation chronic non-infectious lung disease
Online Access:	http://oncohematology.abvpress.ru/index.php/ongm/article/view/136

Similar Items

Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation
by: Yu. V. Skvortsova, et al.
Published: (2015-06-01)

SECONDARY SOLID TUMORS IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION: CASE REPORTS AND LITERATURE REVIEW
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant
by: Peter Riddell, et al.
Published: (2021-04-01)

Hematopoietic stem cell transplantation in juvenile myelomonocytic leukemia: analyse one centre experience and literature review
by: M. A. Maschan, et al.
Published: (2014-07-01)

Hematopoietic stem cell transplantation in juvenile myelomonocytic leukemia: analyse one centre experience and literature review
by: M. A. Maschan, et al.
Published: (2014-07-01)

A comparison of the effect of xinruibai versus filgrastim on hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation
by: Qixiang Ye, et al.
Published: (2018-05-01)

How Allogeneic Hematopoietic Stem Cell Transplantation has Evolved Over Time: 30-Years’ Experience at a Single Institution
by: Manuel Abecasis, et al.
Published: (2020-02-01)

Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
by: Reena V. Jayani, et al.
Published: (2021-03-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Allogenic Hematopoietic Stem Cell Transplantation from Related Donors in Fanconi Anemia
by: Amir Ali Hamidieh, et al.
Published: (2009-01-01)

Allogenic Hematopoietic Stem Cell Transplantation from Related Donors in Fanconi Anemia
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-03-01)

Mobilization of hematopoietic stem cells (HSCs) by using Pleriksafor (Mozobail) in combinationwith colony-stimulating factor in patients with previous failure transplant procurement for autotransplantation of HSCs
by: N B Mikhailova, et al.
Published: (2014-03-01)

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
by: Maiia V. Firsova, et al.
Published: (2021-07-01)

Endothelial injury syndromes after hematopoietic stem cell transplantation: analyzing clinical case
by: Y. V. Skvortsova, et al.
Published: (2022-11-01)

IMMUNE STATE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AT LATE TERMS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: N. V. Minaeva, et al.
Published: (2014-07-01)

Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes
by: Taha Al-Juhaishi, et al.
Published: (2022-01-01)

Editorial: Advances in Pediatric Hematopoietic Cell Therapies and Transplantation
by: Emmanuel Katsanis, et al.
Published: (2022-01-01)

Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report
by: Elmira I. Kolgaeva, et al.
Published: (2021-07-01)

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
by: Kharfan-Dabaja Mohamed A, et al.
Published: (2013-01-01)

Toxoplasma gondii infection in children after allogeneic hematopoietic stem cell transplantation: A case report and literature review
by: Lijuan Luo, et al.
Published: (2021-09-01)

Risk factors for late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: analysis of 227 cases
by: XIONG Yiying, et al.
Published: (2021-11-01)

Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation
by: Panpan Zhu, et al.
Published: (2024-03-01)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
by: Jiali Li, et al.
Published: (2020-09-01)

The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell Transplantation
by: Meng Shan, et al.
Published: (2022-04-01)

Aetiology of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
by: Vasilieva V.A., et al.
Published: (2018-08-01)

Association between conditioning intensity and height growth after allogeneic hematopoietic stem cell transplantation in children
by: Suguru Uemura, et al.
Published: (2023-08-01)

Features of transfusion therapy in hematopoietic stem cell transplantation
by: M. A. Kucher, et al.
Published: (2016-12-01)

Hematopoietic Stem Cell Niche During Homeostasis, Malignancy, and Bone Marrow Transplantation
by: Yan Man, et al.
Published: (2021-01-01)

CLINICAL EFFECTS OF MESENCHYMAL STROMAL CELLS IN LYMPHOMA PATIENTS WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: E. V. Batorov, et al.
Published: (2012-05-01)

АВ0-INCOMPATIBILITY IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: 15-YEARS EXPERIENCE OF R.M. GORBACHEVA MEMORIAL RESEARCH INSTITUTE FOR CHILDREN ONCOLOGY, HEMATOLOGY AND TRANSPLANTATION
by: M. A. Kucher, et al.
Published: (2017-01-01)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
by: Masoud Mardani, et al.
Published: (2020-12-01)

The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety
by: Gaganvir Parmar, et al.
Published: (2023-03-01)

Refractory ascites with liver fibrosis developed in late phase allogeneic hematopoietic stem cell transplantation: report of three patients
by: Hiroki Hosoi, et al.
Published: (2016-06-01)

Mesenchymal stromal cell-derived extracellular vesicles: novel approach in hematopoietic stem cell transplantation
by: Davod Pashoutan Sarvar, et al.
Published: (2022-05-01)

Monitoring of resistanceassociated mutations in UL97 gene of cytomegalovirus in children after allogeneic hematopoietic stem cell transplantation
by: Kozhushnaya O.S., et al.
Published: (2022-03-01)

EVALUATION OF QUALITATIVE AND QUANTITATIVE INDICATORS OF SUBSTITUTIONARY TRANSFUSION THERAPY IN DIFFERENT TYPES OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: M. A. Kucher, et al.
Published: (2017-03-01)

Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study
by: Yue Lu, et al.
Published: (2023-01-01)

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
by: Michael M. B. Green, et al.
Published: (2016-08-01)